非常感谢大家的关注，经过PMI与‘’SARS-CoV-2表面蛋白糖基化分析‘’文章作者的沟通，我们将于2020年五月四日举办Webinar为大家进一步介绍病毒糖基化分析相关内容。欢迎大家点击“阅读原文”注册我们的Webinar！ PMI，公众号：ProteinMetrics文献速递：SARS-CoV-2表面蛋白糖基化分析
Webinar Summary
Scientists worldwide are working tirelessly to develop a vaccine for SARS-CoV-2 (the COVID-19 beta coronavirus), focusing on the humoral immune response to the spike (S) glycoprotein. Understanding the S protein’s glycosylation can reveal fundamental features of viral biology for use in the development and manufacturing of serological testing kits and potential vaccines.
In this webinar, Max Crispin and Joel Allen will share how they characterized both the site-specific N-linked glycan composition and the degree of sequon occupancy on a soluble, native-like SARS-CoV-2 S protein. The sequon occupancy likely plays a role in immune evasion and occlusion of immunogenic proteins.
Marshall Bern of Protein Metrics will also share how Protein Metrics’ advanced analytical software contributes detailed benchmarking of virus glycosylation.
Attendees can expect to learn how to:
-
Conduct detailed site-specific glycosylation analysis using mass spectrometry and advanced protein characterization software
-
Rapidly compare different immunogens and target strategies for detection and vaccine development
-
Map glycan processing states and show how SARS-CoV-2 glycan processing differs from that of typical host glycans
-
Analyze oligomannose and hybrid-type glycan quantities
Speaker Information:
Max Crispin, D. Phil.
Professor of Glycobiology
University of Southampton, UK
Joel Allen
Researcher
University of Southampton, UK
Marshall Bern, Ph.D.
VP of Research and Co-Founder
Protein Metrics Inc